# Treatment for CI-DME in Eyes With Very Good VA Study

> **NCT01909791** · PHASE3 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 702 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **PROCEDURE:** Prompt Laser
- **DRUG:** Prompt aflibercept
- **PROCEDURE:** Deferred laser
- **DRUG:** Deferred aflibercept

## Key facts

- **NCT ID:** NCT01909791
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2018-09-11
- **Final completion:** 2018-09-11
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2020-07-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01909791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01909791, "Treatment for CI-DME in Eyes With Very Good VA Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01909791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*